
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $97.8M | $75.6M | $150M | $57.2M | $148.3M | |
Revenue Growth (YoY) | 57.62% | -22.63% | 98.32% | -61.88% | 159.37% | |
Cost of Revenues | -- | $2.7M | $7.4M | $8.2M | $12.3M | |
Gross Profit | $97.8M | $73M | $142.6M | $49M | $136M | |
Gross Profit Margin | -- | 96.5% | 95.08% | 85.62% | 91.71% | |
R&D Expenses | $193.2M | $214.6M | $207M | $166.6M | $177.2M | |
Selling, General & Admin | $42.7M | $63M | $58.9M | $52.2M | $71M | |
Other Inc / (Exp) | $1.3M | -- | -- | $150.9M | $36.3M | |
Operating Expenses | $228.8M | $275.8M | $264.1M | $217.2M | $246.6M | |
Operating Income | -$131.1M | -$202.8M | -$121.4M | -$168.2M | -$110.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$129.7M | -$202.1M | -$119.8M | -$9.1M | -$66M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | $944K | |
Net Income to Company | -$129.7M | -$202.1M | -$119.8M | -$9.1M | -$67M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$129.7M | -$202.1M | -$119.8M | -$9.1M | -$67M | |
Basic EPS (Cont. Ops) | -$2.47 | -$3.37 | -$1.95 | -$0.15 | -$1.07 | |
Diluted EPS (Cont. Ops) | -$2.47 | -$3.37 | -$1.95 | -$0.15 | -$1.07 | |
Weighted Average Basic Share | $52.4M | $59.9M | $61.4M | $61.9M | $62.6M | |
Weighted Average Diluted Share | $52.4M | $59.9M | $61.4M | $61.9M | $62.6M | |
EBITDA | -$119.1M | -$190.9M | -$107.9M | $2M | -$57.4M | |
EBIT | -$131.1M | -$202.1M | -$119.8M | -$7.6M | -$64.9M | |
Revenue (Reported) | $97.8M | $75.6M | $150M | $57.2M | $148.3M | |
Operating Income (Reported) | -$131.1M | -$202.8M | -$121.4M | -$168.2M | -$110.6M | |
Operating Income (Adjusted) | -$131.1M | -$202.1M | -$119.8M | -$7.6M | -$64.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $16.1M | $10.7M | $24.5M | $9.1M | $13.2M | |
Revenue Growth (YoY) | 23.94% | -33.59% | 129.51% | -62.84% | 44.9% | |
Cost of Revenues | $17K | $48K | $3.5M | $2.1M | $5.4M | |
Gross Profit | $16.1M | $10.6M | $21M | $7M | $7.8M | |
Gross Profit Margin | 99.89% | 99.55% | 85.62% | 76.76% | 59.07% | |
R&D Expenses | $53.1M | $61.4M | $45.9M | $46M | $39.7M | |
Selling, General & Admin | $15M | $16.3M | $13.5M | $14.7M | $10.7M | |
Other Inc / (Exp) | $21K | -- | -- | -- | -- | |
Operating Expenses | $67.3M | $77.3M | $59.4M | $60.7M | $50.4M | |
Operating Income | -$51.3M | -$66.6M | -$38.4M | -$53.8M | -$42.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$51.3M | -$66.4M | -$38M | -$52.2M | -$41M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$51.3M | -$66.4M | -$38M | -$52.2M | -$41M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$51.3M | -$66.4M | -$38M | -$52.2M | -$41M | |
Basic EPS (Cont. Ops) | -$0.90 | -$1.08 | -$0.61 | -$0.84 | -$0.65 | |
Diluted EPS (Cont. Ops) | -$0.90 | -$1.08 | -$0.61 | -$0.84 | -$0.65 | |
Weighted Average Basic Share | $57.2M | $61.3M | $61.8M | $62.3M | $63M | |
Weighted Average Diluted Share | $57.2M | $61.3M | $61.8M | $62.3M | $63M | |
EBITDA | -$48.6M | -$63.5M | -$34.4M | -$49.2M | -$39.2M | |
EBIT | -$51.3M | -$66.4M | -$37.4M | -$51.1M | -$40.9M | |
Revenue (Reported) | $16.1M | $10.7M | $24.5M | $9.1M | $13.2M | |
Operating Income (Reported) | -$51.3M | -$66.6M | -$38.4M | -$53.8M | -$42.6M | |
Operating Income (Adjusted) | -$51.3M | -$66.4M | -$37.4M | -$51.1M | -$40.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $100.9M | $69.4M | $163.4M | $41.8M | $152.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $2.7M | $10.9M | $6.8M | $15.6M | |
Gross Profit | $100.9M | $66.8M | $152.6M | $35M | $136.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $197.4M | $222.9M | $191.5M | $166.7M | $170.9M | |
Selling, General & Admin | $47.5M | $64.2M | $56.2M | $53.4M | $67.1M | |
Other Inc / (Exp) | $621K | $445K | -- | $150.9M | $36.3M | |
Operating Expenses | $237.8M | $284.9M | $245.8M | $218.6M | $236.3M | |
Operating Income | -$136.9M | -$218.1M | -$93.2M | -$183.6M | -$99.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$136.3M | -$217.3M | -$91.3M | -$23.2M | -$54.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$136.3M | -$217.3M | -$91.3M | -$23.2M | -$55.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$136.3M | -$217.3M | -$91.3M | -$23.2M | -$55.8M | |
Basic EPS (Cont. Ops) | -$2.48 | -$3.55 | -$1.47 | -$0.38 | -$0.89 | |
Diluted EPS (Cont. Ops) | -$2.48 | -$3.55 | -$1.47 | -$0.39 | -$0.89 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$125.3M | -$205.8M | -$78.7M | -$12.8M | -$47.3M | |
EBIT | -$136.9M | -$217.3M | -$90.7M | -$21.3M | -$54.8M | |
Revenue (Reported) | $100.9M | $69.4M | $163.4M | $41.8M | $152.4M | |
Operating Income (Reported) | -$136.9M | -$218.1M | -$93.2M | -$183.6M | -$99.5M | |
Operating Income (Adjusted) | -$136.9M | -$217.3M | -$90.7M | -$21.3M | -$54.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $16.1M | $10.7M | $24.5M | $9.1M | $13.2M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $17K | $48K | $3.5M | $2.1M | $5.4M | |
Gross Profit | $16.1M | $10.6M | $21M | $7M | $7.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $53.1M | $61.4M | $45.9M | $46M | $39.7M | |
Selling, General & Admin | $15M | $16.3M | $13.5M | $14.7M | $10.7M | |
Other Inc / (Exp) | $21K | -- | -- | -- | -- | |
Operating Expenses | $67.3M | $77.3M | $59.4M | $60.7M | $50.4M | |
Operating Income | -$51.3M | -$66.6M | -$38.4M | -$53.8M | -$42.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$51.3M | -$66.4M | -$38M | -$52.2M | -$41M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$51.3M | -$66.4M | -$38M | -$52.2M | -$41M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$51.3M | -$66.4M | -$38M | -$52.2M | -$41M | |
Basic EPS (Cont. Ops) | -$0.90 | -$1.08 | -$0.61 | -$0.84 | -$0.65 | |
Diluted EPS (Cont. Ops) | -$0.90 | -$1.08 | -$0.61 | -$0.84 | -$0.65 | |
Weighted Average Basic Share | $57.2M | $61.3M | $61.8M | $62.3M | $63M | |
Weighted Average Diluted Share | $57.2M | $61.3M | $61.8M | $62.3M | $63M | |
EBITDA | -$48.6M | -$63.5M | -$34.4M | -$49.2M | -$39.2M | |
EBIT | -$51.3M | -$66.4M | -$37.4M | -$51.1M | -$40.9M | |
Revenue (Reported) | $16.1M | $10.7M | $24.5M | $9.1M | $13.2M | |
Operating Income (Reported) | -$51.3M | -$66.6M | -$38.4M | -$53.8M | -$42.6M | |
Operating Income (Adjusted) | -$51.3M | -$66.4M | -$37.4M | -$51.1M | -$40.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $181.1M | $123.5M | $108.9M | $101M | $182.8M | |
Short Term Investments | $91.4M | $120.1M | $45.5M | $128.8M | $18.8M | |
Accounts Receivable, Net | $23.1M | $10.4M | $56.2M | $10.4M | $4.3M | |
Inventory | -- | $4.4M | $1.5M | $1.2M | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $17M | $21.2M | $10.2M | $9.9M | $11.5M | |
Total Current Assets | $312.6M | $279.6M | $222.2M | $251.3M | $217.5M | |
Property Plant And Equipment | $42.2M | $54.3M | $56.9M | $45.7M | $42.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $23.9M | $1.4M | $1.4M | $1.4M | $1.6M | |
Total Assets | $378.7M | $335.2M | $280.5M | $298.4M | $261.7M | |
Accounts Payable | $8M | $15.5M | $4.9M | $6.4M | $5M | |
Accrued Expenses | $34.2M | $33.8M | $29M | $24.2M | $29.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $4M | $4.7M | $4.7M | $3.8M | $4.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $50.7M | $74.6M | $48.6M | $56.1M | $55.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $82.9M | $95.6M | $138.5M | $145.8M | $145.6M | |
Common Stock | $562K | $613K | $617K | $621K | $628K | |
Other Common Equity Adj | -$7K | -$61K | -$5K | -$6K | $4K | |
Common Equity | $295.9M | $239.6M | $142M | $152.6M | $116.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $295.9M | $239.6M | $142M | $152.6M | $116.1M | |
Total Liabilities and Equity | $378.7M | $335.2M | $280.5M | $298.4M | $261.7M | |
Cash and Short Terms | $272.5M | $243.6M | $154.3M | $229.8M | $201.7M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $218.5M | $47.3M | $224.3M | $80.4M | $145.6M | |
Short Term Investments | $124.7M | $136.7M | $17.4M | $103.9M | $8.6M | |
Accounts Receivable, Net | $7.1M | $14.9M | $36.2M | $7.2M | $10.5M | |
Inventory | $6.2M | $4.6M | $1.4M | $1.2M | $9.4M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $18.2M | $14.7M | $9.7M | $9.9M | $8M | |
Total Current Assets | $374.7M | $218.2M | $288.9M | $202.6M | $182.1M | |
Property Plant And Equipment | $40.5M | $36M | $53.2M | $44.5M | $41M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $20.3M | $17.2M | $1.4M | $1.2M | $1.5M | |
Total Assets | $435.4M | $271.4M | $343.5M | $248.3M | $224.6M | |
Accounts Payable | $10.3M | $3.7M | $3.8M | $10.7M | $6.6M | |
Accrued Expenses | $35M | $33M | $28.2M | $18.1M | $27.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $4.2M | $4.8M | $4.4M | $4.1M | $5.4M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $53M | $67.1M | $45.6M | $55.8M | $55.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $84.9M | $93.2M | $234.2M | $142.1M | $145.4M | |
Common Stock | $600K | $613K | $618K | $626K | $631K | |
Other Common Equity Adj | $11K | -$283K | $8K | -$35K | -$1K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $350.5M | $178.2M | $109.3M | $106.2M | $79.1M | |
Total Liabilities and Equity | $435.4M | $271.4M | $343.5M | $248.3M | $224.6M | |
Cash and Short Terms | $343.2M | $184M | $241.7M | $184.2M | $154.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$129.7M | -$202.1M | -$119.8M | -$9.1M | -$67M | |
Depreciation & Amoritzation | $12M | $11.3M | $11.9M | $9.6M | $7.5M | |
Stock-Based Compensation | $20.7M | $23.1M | $20.4M | $18.4M | $29.4M | |
Change in Accounts Receivable | -$10.3M | $12.7M | -$45.8M | $45.9M | $6.1M | |
Change in Inventories | -- | -$6.4M | $55K | $230K | -$2.2M | |
Cash From Operations | -$111.9M | -$143.8M | -$87M | -$78.2M | -$68.4M | |
Capital Expenditures | $5.9M | $6.2M | $3.6M | $1.8M | $3.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$7.8M | -$36.6M | $70.7M | -$80.1M | $149.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | $149.2M | -$2.5M | |
Cash From Financing | $174.3M | $122.8M | $1.7M | $150.4M | $960K | |
Beginning Cash (CF) | $126.5M | $181.1M | $123.5M | $108.9M | $101M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $54.7M | -$57.7M | -$14.6M | -$7.9M | $81.9M | |
Ending Cash (CF) | $181.1M | $123.5M | $108.9M | $101M | $182.8M | |
Levered Free Cash Flow | -$117.8M | -$150M | -$90.6M | -$80M | -$72.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$51.3M | -$66.4M | -$38M | -$52.2M | -$41M | |
Depreciation & Amoritzation | $2.7M | $2.9M | $3M | $1.8M | $1.8M | |
Stock-Based Compensation | $5.3M | $5.3M | $4.8M | $5.6M | $4.4M | |
Change in Accounts Receivable | $15.9M | -$4.5M | $20.1M | $3.1M | -$6.2M | |
Change in Inventories | -$6.2M | -$210K | $42K | -$27K | -$9.4M | |
Cash From Operations | -$29M | -$57.7M | -$12.8M | -$45.6M | -$46.9M | |
Capital Expenditures | $626K | $1.4M | $359K | $1.5M | $529K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$34.3M | -$18.5M | $28.1M | $24.8M | $9.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $99.5M | -$2.4M | -$282K | |
Cash From Financing | $100.7M | $37K | $100.1M | $248K | -$282K | |
Beginning Cash (CF) | $181.1M | $123.5M | $108.9M | $101M | $182.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $37.4M | -$76.1M | $115.4M | -$20.6M | -$37.3M | |
Ending Cash (CF) | $218.5M | $47.3M | $224.3M | $80.4M | $145.6M | |
Levered Free Cash Flow | -$29.7M | -$59.1M | -$13.2M | -$47.1M | -$47.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$136.3M | -$217.3M | -$91.3M | -$23.2M | -$55.8M | |
Depreciation & Amoritzation | $11.6M | $11.4M | $11.9M | $8.5M | $7.5M | |
Stock-Based Compensation | $21.5M | $23.1M | $20M | $19.1M | $28.3M | |
Change in Accounts Receivable | $4.7M | -$7.8M | -$21.3M | $28.9M | -$3.3M | |
Change in Inventories | -$6.2M | -$462K | $307K | $161K | -$11.6M | |
Cash From Operations | -$96.8M | -$172.5M | -$42.1M | -$111M | -$69.6M | |
Capital Expenditures | $5.3M | $7M | $2.6M | $2.9M | $2.8M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$52.6M | -$20.8M | $117.3M | -$83.4M | $134.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | $47.3M | -$366K | |
Cash From Financing | $274.8M | $22.2M | $101.7M | $50.5M | $430K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $125.4M | -$171.2M | $176.9M | -$143.9M | $65.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$102.1M | -$179.5M | -$44.7M | -$113.9M | -$72.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$51.3M | -$66.4M | -$38M | -$52.2M | -$41M | |
Depreciation & Amoritzation | $2.7M | $2.9M | $3M | $1.8M | $1.8M | |
Stock-Based Compensation | $5.3M | $5.3M | $4.8M | $5.6M | $4.4M | |
Change in Accounts Receivable | $15.9M | -$4.5M | $20.1M | $3.1M | -$6.2M | |
Change in Inventories | -$6.2M | -$210K | $42K | -$27K | -$9.4M | |
Cash From Operations | -$29M | -$57.7M | -$12.8M | -$45.6M | -$46.9M | |
Capital Expenditures | $626K | $1.4M | $359K | $1.5M | $529K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$34.3M | -$18.5M | $28.1M | $24.8M | $9.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $99.5M | -$2.4M | -$282K | |
Cash From Financing | $100.7M | $37K | $100.1M | $248K | -$282K | |
Beginning Cash (CF) | $181.1M | $123.5M | $108.9M | $101M | $182.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $37.4M | -$76.1M | $115.4M | -$20.6M | -$37.3M | |
Ending Cash (CF) | $218.5M | $47.3M | $224.3M | $80.4M | $145.6M | |
Levered Free Cash Flow | -$29.7M | -$59.1M | -$13.2M | -$47.1M | -$47.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.